Author:
Hansel Nadia N.,Ruczinski Ingo,Rafaels Nicholas,Sin Don D.,Daley Denise,Malinina Alla,Huang Lili,Sandford Andrew,Murray Tanda,Kim Yoonhee,Vergara Candelaria,Heckbert Susan R.,Psaty Bruce M.,Li Guo,Elliott W. Mark,Aminuddin Farzian,Dupuis Josée,O’Connor George T.,Doheny Kimberly,Scott Alan F.,Boezen H. Marike,Postma Dirkje S.,Smolonska Joanna,Zanen Pieter,Mohamed Hoesein Firdaus A.,de Koning Harry J.,Crystal Ronald G.,Tanaka Toshiko,Ferrucci Luigi,Silverman Edwin,Wan Emily,Vestbo Jorgen,Lomas David A.,Connett John,Wise Robert A.,Neptune Enid R.,Mathias Rasika A.,Paré Peter D.,Beaty Terri H.,Barnes Kathleen C.
Publisher
Springer Science and Business Media LLC
Subject
Genetics(clinical),Genetics
Reference38 articles.
1. Anthonisen NR, Connett JE, Kiley JP, Altose MD, Bailey WC, Buist AS, Conway WA Jr, Enright PL, Kanner RE, O’Hara P (1994) Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA 272:1497–1505
2. Anthonisen NR, Lindgren PG, Tashkin DP, Kanner RE, Scanlon PD, Connett JE (2005) Bronchodilator response in the lung health study over 11 years. Eur Respir J 26:45–51
3. Bakke PS, Zhu G, Gulsvik A, Kong X, Agusti AG, Calverley PM, Donner CF, Levy RD, Make BJ, Pare PD, Rennard SI, Vestbo J, Wouters EF, Anderson W, Lomas DA, Silverman EK, Pillai SG (2011) Candidate genes for COPD in two large data sets. Eur Respir J 37:255–263
4. Besnard V, Wert SE, Kaestner KH, Whitsett JA (2005) Stage-specific regulation of respiratory epithelial cell differentiation by Foxa1. Am J Physiol Lung Cell Mol Physiol 289:L750–L759
5. Celli BR, Thomas NE, Anderson JA, Ferguson GT, Jenkins CR, Jones PW, Vestbo J, Knobil K, Yates JC, Calverley PM (2008) Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study. Am J Respir Crit Care Med 178:332–338